Acquisition leverage Dragonfly Health recently completed the acquisition of Enclara Pharmacia, signaling an expanded footprint in pharmacy solutions for hospice and post-acute care, which creates cross-sell opportunities across care-at-home services and integrated pharmacy logistics.

Care-at-home focus Position Dragonfly as a unified care-at-home platform combining pharmacy, DME, logistics, and data to streamline post-acute transitions; opportunities exist to upsell integrated technology and clinical intelligence to providers seeking to reduce clinician burden and improve outcomes.

Leadership momentum Recent executive appointments in human resources indicate a focus on talent and organizational capability; highlight potential for selling workforce management, training, and HR tech integrations to scale operations and improve clinician engagement.

Financial scale With revenue in the upper hundreds of millions range and a substantial employee base, Dragonfly is a mature growth-stage customer likely open to enterprise-grade solutions in data analytics, cybersecurity, and scalable healthcare IT to support expanding service lines.

Tech-leaning ops Existing tech stack and data-driven approach suggest receptivity to partnerships around cloud-enabled data platforms, analytics, interoperability, and workflow automation that reduce fragmentation across post-acute care ecosystems.